Recently, sdAbs as targeting moieties have become attractive due to their unique therapeutic merits, such as targeting occluded epitopes, deep tumor penetration and high expression level and stability, etc. Here, we identified a fully human antibody VH domain (VH20) that targets human ALK with high specificity and affinity. This evidence concerns the gene ALK and neoplasm.